Use of tasteless, hydrolyzed collagen and agent containing the same
AssigneeDGF Stoess AG
InventorsAdam Milan, Bernd Eggersgluss, Klaus Braumer, Reinhard Schrieber
Life of this patent
Estimating the term…
Abstract
Tasteless, hydrolyzed collagen from gelatin, gelatin or animal collagenic connective tissue having an average molecular weight of from 1 to 40 kD for the preparation of agents for the treatment of osteoporosis. It may be combined with conventional agents for combatting osteoporosis, such as calcitonin, calcium salts, and/or progesterone.
Claims8
A method of treating osteoporosis comprising administering to a patient in need thereof a composition comprising tasteless, enzymatically hydrolyzed collagen from gelatin or animal collagenic connective tissue having an average molecular weight of from 1 to 40 kD, as determined by HPLC with non-globular standard peptides from collagen.
A composition for treating osteoporosis comprising tasteless, enzymatically hydrolyzed collagen from gelatin or animal collagenic connective tissue having an average molecular weight of from 1 to 40 kD, as determined by HPLC with non-globular standard peptides from collagen, in combination with calcitonin, calcium salts, and/or progesterone.
Dependencies are inferred from the claim text.